Pharma-Bio Serv, Inc. (PBSV)
USD 0.46
(-9.8%)
USD 0.46
(-9.8%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.11 Million USD | -4.9% |
| 2022 | 1.17 Million USD | 130.49% |
| 2021 | -3.85 Million USD | -273.16% |
| 2020 | 2.22 Million USD | 31.17% |
| 2019 | 1.69 Million USD | 55.91% |
| 2018 | 1.08 Million USD | 176.36% |
| 2017 | -1.42 Million USD | -1453.14% |
| 2016 | -91.75 Thousand USD | -105.15% |
| 2015 | 1.78 Million USD | -37.81% |
| 2014 | 2.86 Million USD | -52.83% |
| 2013 | 6.07 Million USD | 5.9% |
| 2012 | 5.73 Million USD | 66.1% |
| 2011 | 3.45 Million USD | 466.0% |
| 2010 | 609.89 Thousand USD | -33.38% |
| 2009 | 915.45 Thousand USD | -65.5% |
| 2008 | 2.65 Million USD | -27.25% |
| 2007 | 3.64 Million USD | -6.18% |
| 2006 | 3.88 Million USD | 19539.55% |
| 2005 | -20 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -313.38 Thousand USD | 28.5% |
| 2024 Q3 | -381.78 Thousand USD | -21.83% |
| 2024 Q1 | -438.3 Thousand USD | -746.71% |
| 2023 Q1 | 328.63 Thousand USD | 94.5% |
| 2023 Q4 | -51.76 Thousand USD | -111.24% |
| 2023 Q3 | 460.46 Thousand USD | 21.15% |
| 2023 FY | 1.11 Million USD | -4.9% |
| 2023 Q2 | 380.07 Thousand USD | 15.65% |
| 2022 FY | 1.17 Million USD | 130.49% |
| 2022 Q3 | 369.5 Thousand USD | 31.67% |
| 2022 Q2 | 280.63 Thousand USD | -21.14% |
| 2022 Q1 | 355.84 Thousand USD | 107.42% |
| 2022 Q4 | 168.96 Thousand USD | -54.27% |
| 2021 Q2 | 264.77 Thousand USD | -17.03% |
| 2021 FY | -3.85 Million USD | -273.16% |
| 2021 Q1 | 319.12 Thousand USD | 110.34% |
| 2021 Q3 | 360.49 Thousand USD | 36.15% |
| 2021 Q4 | -4.79 Million USD | -1430.99% |
| 2020 Q4 | 151.71 Thousand USD | -81.42% |
| 2020 Q1 | 536.75 Thousand USD | 25.83% |
| 2020 FY | 2.22 Million USD | 31.17% |
| 2020 Q2 | 720.38 Thousand USD | 34.21% |
| 2020 Q3 | 816.69 Thousand USD | 13.37% |
| 2019 FY | 1.69 Million USD | 55.91% |
| 2019 Q4 | 426.55 Thousand USD | -3.61% |
| 2019 Q1 | 432.5 Thousand USD | -64.89% |
| 2019 Q2 | 782.74 Thousand USD | 80.98% |
| 2019 Q3 | 442.54 Thousand USD | -43.46% |
| 2018 Q4 | 1.23 Million USD | 234.5% |
| 2018 Q3 | 368.23 Thousand USD | 346.89% |
| 2018 Q2 | -149.15 Thousand USD | -878.36% |
| 2018 Q1 | 19.16 Thousand USD | 103.67% |
| 2018 FY | 1.08 Million USD | 176.36% |
| 2017 Q4 | -522.32 Thousand USD | -168.89% |
| 2017 Q3 | -194.25 Thousand USD | 40.15% |
| 2017 Q2 | -324.56 Thousand USD | 15.48% |
| 2017 Q1 | -383.99 Thousand USD | 14.62% |
| 2017 FY | -1.42 Million USD | -1453.14% |
| 2016 Q3 | -120.78 Thousand USD | -227.63% |
| 2016 Q4 | -449.75 Thousand USD | -272.36% |
| 2016 Q1 | 384.14 Thousand USD | -32.08% |
| 2016 Q2 | 94.63 Thousand USD | -75.36% |
| 2016 FY | -91.75 Thousand USD | -105.15% |
| 2015 Q1 | 328.44 Thousand USD | -64.26% |
| 2015 FY | 1.78 Million USD | -37.81% |
| 2015 Q4 | 565.58 Thousand USD | 14.19% |
| 2015 Q3 | 495.32 Thousand USD | 26.36% |
| 2015 Q2 | 391.99 Thousand USD | 19.35% |
| 2014 Q3 | 698.26 Thousand USD | 66.54% |
| 2014 Q4 | 919 Thousand USD | 31.61% |
| 2014 Q1 | 827.62 Thousand USD | -44.84% |
| 2014 FY | 2.86 Million USD | -52.83% |
| 2014 Q2 | 419.26 Thousand USD | -49.34% |
| 2013 Q4 | 1.5 Million USD | -2.16% |
| 2013 FY | 6.07 Million USD | 5.9% |
| 2013 Q3 | 1.53 Million USD | -12.26% |
| 2013 Q2 | 1.74 Million USD | 35.45% |
| 2013 Q1 | 1.29 Million USD | -6.04% |
| 2012 FY | 5.73 Million USD | 66.1% |
| 2012 Q4 | 1.37 Million USD | -12.68% |
| 2012 Q3 | 1.57 Million USD | 10.3% |
| 2012 Q2 | 1.42 Million USD | 4.69% |
| 2012 Q1 | 1.36 Million USD | 32.21% |
| 2011 Q3 | 1.16 Million USD | 58.48% |
| 2011 Q4 | 1.03 Million USD | -11.77% |
| 2011 FY | 3.45 Million USD | 466.0% |
| 2011 Q1 | 517.52 Thousand USD | 86.49% |
| 2011 Q2 | 736.75 Thousand USD | 42.36% |
| 2010 FY | 609.89 Thousand USD | -33.38% |
| 2010 Q2 | 78.31 Thousand USD | 58.8% |
| 2010 Q4 | 277.5 Thousand USD | 35.53% |
| 2010 Q3 | 204.75 Thousand USD | 161.46% |
| 2010 Q1 | 49.31 Thousand USD | -74.91% |
| 2009 Q2 | 405.97 Thousand USD | 170.98% |
| 2009 Q3 | 163.13 Thousand USD | -59.82% |
| 2009 Q4 | 196.53 Thousand USD | 20.48% |
| 2009 FY | 915.45 Thousand USD | -65.5% |
| 2009 Q1 | 149.81 Thousand USD | -74.77% |
| 2008 Q4 | 593.84 Thousand USD | -29.45% |
| 2008 Q2 | 671.78 Thousand USD | 22.92% |
| 2008 Q1 | 546.51 Thousand USD | -16.4% |
| 2008 FY | 2.65 Million USD | -27.25% |
| 2008 Q3 | 841.68 Thousand USD | 25.29% |
| 2007 FY | 3.64 Million USD | -6.18% |
| 2007 Q4 | 653.75 Thousand USD | -49.35% |
| 2007 Q3 | 1.29 Million USD | 30.57% |
| 2007 Q2 | 988.61 Thousand USD | 38.34% |
| 2007 Q1 | 714.61 Thousand USD | -40.58% |
| 2006 Q3 | 762.19 Thousand USD | -12.75% |
| 2006 Q4 | 1.2 Million USD | 57.78% |
| 2006 Q2 | 873.56 Thousand USD | 20.22% |
| 2006 FY | 3.88 Million USD | 19539.55% |
| 2006 Q1 | 726.62 Thousand USD | 0.0% |
| 2005 FY | -20 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Achiko AG | -8.35 Million USD | 113.374% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 4.7 Million USD | 76.239% |
| Cannabis Sativa, Inc. | -855.85 Thousand USD | 230.561% |
| CompuMed, Inc. | -31.2 Thousand USD | 3681.216% |
| CompuGroup Medical SE & Co. KGaA | 171.25 Million USD | 99.348% |
| Cogstate Limited | 660.18 Thousand USD | -69.257% |
| CareView Communications, Inc. | -688.3 Thousand USD | 262.343% |
| Craneware plc | 19.73 Million USD | 94.338% |
| Caduceus Software Systems Corp. | -1.15 Million USD | 196.808% |
| Certive Solutions Inc. | -2.1 Million USD | 153.187% |
| Drug Free Solution, Inc. | -1.4 Million USD | 179.402% |
| DATATRAK International, Inc. | 1.87 Million USD | 40.529% |
| Strainsforpains, Inc. | -65.61 Thousand USD | 1803.111% |
| Healixa Inc. | -6.35 Million USD | 117.587% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 9.02 Million USD | 87.615% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | -983.56 Thousand USD | 213.609% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | -789.33 USD | 141664.491% |
| IQ-AI Limited | -517.25 Thousand USD | 316.026% |
| Cannabiz Mobile, Inc. | -750.00 USD | 149088.133% |
| Mednow Inc. | -17.04 Million USD | 106.557% |
| Galileo Life Sciences, Inc. | -271.37 Thousand USD | 511.764% |
| MediXall Group, Inc. | -6.54 Million USD | 117.085% |
| Mitesco, Inc. | -2.58 Million USD | 143.199% |
| MobileSmith, Inc. | -7.81 Million USD | 114.294% |
| NantHealth, Inc. | -51.32 Million USD | 102.177% |
| Net Medical Xpress Solutions, Inc. | -1.82 Million USD | 161.362% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | -12.15 Million USD | 109.19% |
| Patient Access Solutions, Inc. | -9 Million USD | 112.41% |
| PPJ Healthcare Enterprises, Inc. | 74.72 Thousand USD | -1395.304% |
| Medical Cannabis Payment Solutions, Inc. | -34.1 Thousand USD | 3376.865% |
| Renalytix Plc | -29.6 Million USD | 103.774% |
| Revium Recovery Inc. | -679 Thousand USD | 264.567% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 396.65 Thousand USD | -181.712% |
| Vaso Corporation | 4.19 Million USD | 73.363% |
| Vynleads, Inc. | -235.73 Thousand USD | 574.022% |